Skip to content

Efficacy of acceptance and commitment group therapy along with forgiveness on hope of women with breast cancer.

Efficacy of acceptance and commitment group therapy along with forgiveness on hope of women with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012081810372N2
Enrollment
34
Registered
2014-04-30
Start date
2013-06-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Breast, unspecified

Interventions

Intervention 1: There will be no intervention for control group. Intervention 2: For experimental group, the workshop will be held for 12 weeks, a 3-hour-class per week. This workshop will be presente
Behavior
There will be no intervention for control group.
For experimental group, the workshop will be held for 12 weeks, a 3-hour-class per week. This workshop will be presented by a specialist.

Sponsors

Shahid Sadoughi UniversityOf Medical Sciences, Yazd
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Femininity, suffering from breast cancer, having undergone breast surgery, having, at least, a high school diploma. Exclusion criteria: unwillingness to participate in the workshop, becoming ill, specific psychological stress, engaging in any other training course and discontinuity in medical treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hope. Timepoint: Before and after workshop. Method of measurement: Questionnaire.;Hope for Life. Timepoint: Before and after workshop. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Nemati

Shahid Sadoughi University Of Medical Sciences, Yazd

fatima_1102002@yahoo.com+98 35 1822 9004

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026